Cargando…

Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series

BACKGROUND: Current first-line anti-proteinuric treatments for nephrotic syndrome (NS) do not produce an effective response in all patients and are not tolerated by some patients. Additional effective and tolerable treatment options in NS are strongly needed. This retrospective case series is the la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madan, Arvind, Mijovic-Das, Snezana, Stankovic, Ana, Teehan, Geoffrey, Milward, Amber S., Khastgir, Anupa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4815175/ https://www.ncbi.nlm.nih.gov/pubmed/27036111 http://dx.doi.org/10.1186/s12882-016-0241-7

Ejemplares similares

Use of Repository Corticotropin Gel (Acthar) in Progressive Nephrotic Syndrome Secondary to Transplant Glomerulopathy: A Report of Three Cases
por: Markell, Mariana, et al.
Publicado: (2019)

A Narrative Review of Acthar Gel for the Treatment of Myositis
por: Chandra, Tanya, et al.
Publicado: (2023)

Acthar Gel Inhibits the Activation of CD4(+) and CD8(+) T Cells
por: Wright, Dale, et al.
Publicado: (2023)

Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis
por: Hayes, Kyle, et al.
Publicado: (2023)

A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy
por: Hladunewich, Michelle A., et al.
Publicado: (2014)

Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel
por: Zhou, Ying, et al.
Publicado: (2015)

Direct effects of HP Acthar Gel(®) on human B lymphocyte activation in vitro
por: Olsen, Nancy J., et al.
Publicado: (2015)

Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence
por: Wan, George J, et al.
Publicado: (2023)

Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis
por: Bindra, Jas, et al.
Publicado: (2023)

H.P. Acthar Gel (repository corticotropin injection) treatment of patients with multiple sclerosis and diabetes
por: Kutz, Christen
Publicado: (2016)

Healthcare Costs and Resource Utilization in Patients with Infantile Spasms Treated with H.P. Acthar Gel(®)
por: Gold, Laura S., et al.
Publicado: (2016)

Acthar(®) Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence
por: Kaplan, Jeffrey, et al.
Publicado: (2023)

Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®)
por: Gold, Laura S., et al.
Publicado: (2016)

Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy
por: Tumlin, James, et al.
Publicado: (2017)

A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse
por: Kaplan, Jeffrey, et al.
Publicado: (2020)

Repository Corticotropin Injection (Acthar(®) Gel) for Refractory Severe Noninfectious Keratitis: Efficacy and Safety from a Phase 4, Multicenter, Open-Label Study
por: Wirta, David, et al.
Publicado: (2021)

Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus
por: Bindra, Jas, et al.
Publicado: (2022)

Membranous glomerulopathy and treatment with Acthar®: a case study
por: Watson, Myra June
Publicado: (2013)

ACTH (Acthar Gel) Reduces Toxic SOD1 Protein Linked to Amyotrophic Lateral Sclerosis in Transgenic Mice: A Novel Observation
por: Arrat, Hasan, et al.
Publicado: (2015)

Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar(®) Gel) for Persistently Active Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2021)

Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2021)

Acthar Gel (repository corticotropin injection) for persistently active SLE: study design and baseline characteristics from a multicentre, randomised, double-blind, placebo-controlled trial
por: Askanase, Anca D, et al.
Publicado: (2020)

Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel
por: Bomback, Andrew S, et al.
Publicado: (2011)

Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
por: Ma, Xiaoyan, et al.
Publicado: (2023)

Rituximab treatment for difficult-to-treat nephrotic syndrome in children:a multicenter, retrospective study
por: TAŞDEMİR, Mehmet, et al.
Publicado: (2021)

An Update on the Controversies in Anemia Management in Chronic Kidney Disease: Lessons Learned and Lost
por: Teehan, Geoffrey, et al.
Publicado: (2011)

Revised guidelines for management of steroid-sensitive nephrotic syndrome
por: Bagga, Arvind
Publicado: (2008)

Friedreich Ataxia and nephrotic syndrome: a series of two patients
por: Shinnick, Julianna E., et al.
Publicado: (2016)

Genetic Variations and Clinical Features of NPHS1-Related Nephrotic Syndrome in Chinese Children: A Multicenter, Retrospective Study
por: Rong, Liping, et al.
Publicado: (2021)

Acute myocardial infarction in patients of nephrotic syndrome: a case series
por: Xie, Liang, et al.
Publicado: (2017)

Thromboembolic complications in children with primary nephrotic syndrome: A Tunisian series
por: Boussetta, Abir, et al.
Publicado: (2022)

REM sleep latency and neurocognitive dysfunction in schizophrenia
por: Das, Mrinmay, et al.
Publicado: (2005)

SARS-CoV-2 infection in children with nephrotic syndrome
por: Krishnasamy, Sudarsan, et al.
Publicado: (2022)

Ponticelli regimen in idiopathic nephrotic syndrome
por: Das, U., et al.
Publicado: (2009)

Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
por: Meena, Jitendra, et al.
Publicado: (2020)

Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
por: Sinha, Aditi, et al.
Publicado: (2021)

Is influenza vaccination associated with nephrotic syndrome relapse in children? A multicenter prospective study
por: Ishimori, Shingo, et al.
Publicado: (2022)

Problems in estimating maternal effects
por: Teehan, TJ
Publicado: (1980)

Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series
por: Levine, Todd
Publicado: (2012)

Apheresis Therapy for Steroid-Resistant Idiopathic Nephrotic Syndrome: Report on a Case Series
por: Naciri Bennani, Hamza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_avmjghoku76ka2f867r46t63uq